番茄社区

Greg Laub

Greg Laub

Authors >

Greg Laub

Greg Laub joined 番茄社区 in 2005 as Production Manager and led the launch of the video department in 2007. He currently leads the video and podcast production teams. Greg's passion to craft a story began as a writer, with stops as Managing Editor at USOpen.org, Creative Director at Bernard Hodes Advertising, and copywriter at AOL Time Warner. He's even had one of his screenplays produced -- he believes it was beloved by all seven people who saw it. Greg lives in New Jersey with his wife, two kids and two dogs.

Connect:

email image

Latest from Greg Laub

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

New treatments reshape metastatic and muscle-invasive bladder cancer therapy

Use of Home-Based OCT for Neovascular AMD Could Lead to More Timely Treatment

Analysis of home OCT data suggested that 57% of patients should have been treated earlier

Sustained Viral Suppression in Multidrug-Resistant HIV With Lenacapavir at 3 Years

No virologic failures or resistance seen; CD4 counts continue to rise

DHA Levels in the Brain Tied to Cognitive Function in APOE4 Carriers

High-dose omega-3 supplementation showed no benefit, however

Myasthenia Gravis: Balancing Traditional Immunotherapies vs Newer Medications

Michael Hehir, MD, on aligning the treatment to what a patient needs

Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

Gene-Editing Therapy Shows Promise in Hereditary Angioedema

Phase II study shows reductions of 75% and 77% in attack rates with 25- and 50-mg doses

A Potential Reason Behind COVID Vaccines' Waning Benefit

Long-lived plasma cell compartment in the bone marrow may hold the answer, says researcher

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with complete response can have long treatment-free interval, study suggests

Faricimab vs Aflibercept in Diabetic Macular Edema

9-month difference in time to first drying of the retina with faricimab, analysis shows

1

鈥�